SCHEMBL5223732

SCHEMBL5223732

COC(=O)c1cc(/C=C/c2ccccc2)cc(N2CCCC2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
HPGD P15428 2/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 2/20 0.49
TSHR P16473 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
POLB P06746 2/20 0.47
RXFP1 Q9HBX9 1/20 0.46
DUSP3 P51452 1/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223738 1.00 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5222704 0.89 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5222712 0.89 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5225686 0.87 KMT2A (0.46) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5225688 0.87 KMT2A (0.46) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5219444 0.82 MEN1 (0.56) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL475775 0.82 MEN1 (0.56) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5218127 0.82 KMT2A (0.46) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5854074 0.82 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD
SCHEMBL5221306 0.81 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP2D6CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed